Dr. Melaxin is represented by the Niacinamide Picotonic Shot Pigmentation Cream. The narrow product scope matters: a medical-sounding brand name and a large ppm figure should not determine how a reader classifies the preparation. This entry treats it as a cosmetic with a documented ingredient amount.
Our October 14, 2026 review used the official US listing and detailed return policy. No cream was applied and no transaction was performed. We connect the formula declaration to its purchase conditions so the brand summary remains useful without inventing a personal-use endorsement.
Read the amount in ordinary percentage terms
Twenty thousand parts per million corresponds to 2% niacinamide. The conversion does not establish an unusually strong prescription equivalent or quantify visible improvement. The cream review retains the actual amount and the rest of the formula context. [1]
Fragrance appears in the declaration. That detail belongs in a comparison of routines, even when the headline emphasizes brightening. We did not establish a completed melasma-specific trial or determine individual tolerance; AAD’s self-care discussion supplies context for keeping irritation questions visible. [4]
Separate a sale display from transaction performance
The product page showed $26 beside $42, with no independent verification of the larger price’s historical basis. Final checkout charges were not observed. A stated dispatch period should not become a delivery guarantee or a claim that customer support responds within the same period. [1]
The policy describes fourteen days from receipt, unused-item eligibility, customer return postage and other deductions or exclusions. Those terms do not justify an unrestricted opened-product refund promise. The selected order needs its own eligibility check, and this publication did not request an exception. [2]
A cosmetic inclusion does not settle the diagnosis
AAD distinguishes the assessment of melasma from simply identifying a dark area on the skin. The guide linked from this profile explains why a retail product’s intended audience cannot supply that diagnosis or establish the best treatment for a particular reader. [3]
The sponsored CoreAge Rx feature remains separate from this assessment. Dr. Melaxin’s entry documents an offer and its limits; it does not rank the cream against prescribed care or claim that a large ingredient number predicts a faster, more complete or more durable result.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Niacinamide Picotonic Shot Pigmentation Cream – Dr.Melaxin.usOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Shipping & Return – Dr.Melaxin.usOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- AAD: melasma diagnosis and treatmentAAD guidance rechecked October 10, 2026. · Checked October 14, 2026
- AAD: melasma self-careAAD guidance rechecked October 10, 2026. · Checked October 14, 2026